Discontinued — last reported Q3 '23
Blackrock Interest Paid remained flat by 0.0% to $120.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 66.8%, from $72.25M to $120.50M. Over 3 years (FY 2022 to FY 2025), Interest Paid shows an upward trend with a 39.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $177.00M | $200.00M | $289.00M | $482.00M |
| YoY Change | — | +13.0% | +44.5% | +66.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.